Clinical Trial Update: Fluoxetine Opens Window to Improve Motor Recovery After Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial investigates fluoxetine as a treatment to improve motor recovery after stroke, reporting completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Stroke, Cerebrovascular Accident | Phase 2 | Status: COMPLETED